The global bioprocess technology market size was USD 21.2 Bn in 2021 and is likely to reach USD 55.4 Bn by 2030, expanding at a CAGR of 10.9% during 2022–2030. The market growth is attributed to the growing investment in bioprocessing technology, rising innovations, and support from various governments worldwide.
Bioprocess technology is the backbone of the biotechnology industry. Bioprocessing involves the use of bio components such as bacteria, enzymes, proteins, living cells, and other bioagents to get the desired transformation of substances. These agents are isolated from biological sources such as humans, plants, animals, microbial, and fungi.
There are several advantages of bioprocess technology over chemical processes. For instance, bio-process needs mild reaction conditions. Bioprocess is more efficient, specific, and eco-friendly as its byproducts are renewable. The invention of recombinant DNA technology has taken applications of bioprocess technology to the next level.
Various products such as vaccines, gene therapy vectors, and therapeutic stem cells are produced using bioprocess technology. In fact, biopharmaceutical products are one of the rapidly growing drug types in the industry. Bioprocessing technology instruments include bioreactors, cell culture products, cell culture equipment, tubing, fittings, and other ancillary equipment, fill and finish equipment, and filtration & sterilization equipment.
COVID-19 Impact on Bioprocess Technology Market
The market report finds that the COVID-19 pandemic slowed the growth of the global market during the initial months of virus spread and lockdowns. The disruption in the supply chain and strict lockdowns implemented by the various worldwide governments slowed down the product demand in the market.
The key players in the global market despite lockdowns kept operations running to ensure business continuity and efficiently provide essential products to various industries such as healthcare, food & beverage, and pharmaceuticals.
The COVID-19 pandemic effect is expected to create growth opportunities for the global market, as there is a rise in demand for bioprocessing technology. The demand increase is attributed to the need for effective vaccines & drugs for various diseases and increasing consumer preferences for chemical-free products.
Bioprocess Technology Market Dynamics
The research report presents a complete market overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global bioprocess technology market report has up-to-date insights about market scenarios that can shape the overall market performance and output during the forecast period, 2022 to 2030.
What are the Key Global Bioprocess Technology Market Trends?
Increasing Applications of Recombinant Proteins in Therapeutics
The application of recombinant proteins is increasing in therapeutics. They play important role in the development of therapeutic medicine. These drugs have several uses in the treatment of various diseases including cancer, anemia, diabetes, and infectious diseases among others. Recombinant proteins are safe from off-target side effects and require a short time for developing than small molecules.
Recombinant proteins are used to understand protein-to-protein interactions. The first recombinant protein used in patient treatment was recombinant human insulin in 1982. Since then, there is rapid growth in the industry. To date, the US FDA has approved more than 132 recombinant proteins for medical use. However, globally more than 170 recombinant proteins are produced and utilized in various clinical applications. All big pharmaceutical companies develop recombinant proteins as drugs, which has increased their value in the industry to multi-billion dollars.
Which Major Factors are Likely to Boost the Demand for Global Bioprocessing Technology Market?
Increasing Demand for Biopharmaceuticals
The increasing demand for biopharmaceuticals is one of the key driving factors for the global market. The advancement in bioprocessing technology has made it possible to increase the production yield and quality of medicines and drugs.
Bioprocessing 4.0 is expected to create life-changing and affordable biologics for patients across the globe. Biologics are now a rapidly growing form of drugs across the world for treating chronic diseases and rare diseases. The drugs manufactured with the help of bioprocessing include vaccines, cell & gene therapies, plasma-derived therapies, and protein-based therapies. The demand for biotherapeutics is growing rapidly in the past few years and is projected to boost the global growth of the market in the near future.
What are the Major Restraining Factors that can Hamper the Global Bioprocessing Technology Market Expansion?
Strict Regulations Imposed by Various Worldwide Governments
Various governments across the world have started regulating the manufacturing process for biopharmaceuticals, cancer therapeutics and biotherapeutics, which is expected to hamper the global market growth during the projection period.
Bioprocessing technology involves dealing with living cells, bacteria, and other such bioagents.
A small mishap or mishandling of substances can cause tremendous danger to the individuals working on the project as well as to outsiders. Governments across the world have realized the potential threats that can happen with bioprocessing technology, owing to which the use is regulated under strict guidelines.
What are the Growth Opportunities in the Global Bioprocessing Technology Market?
Rising Investment in Research and Development of Innovative Solutions
The rising investment from governments, private, and public sector organizations to research and develop various technological advancements and new medicines using bioprocessing is expected to create lucrative growth opportunities for the global market.
Companies in biotechnology, pharmaceuticals, and other related industries are focused on investing in the right direction that enables innovation of advanced production methods, improved product quality, and safety measures. Moreover, the development of new and efficient drugs for chronic diseases with the help of bioprocessing is also expected to aid the global market in creating growth opportunities.
Scope of Bioprocess Technology Market Report
The global bioprocess technology market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Bioprocess Technology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2021
|
|
Historic Data
|
2019–2020
|
|
Forecast Period
|
2022–2030
|
|
Segmentation
|
Type (Cell Culture, Flow Cytometry, Cell Line Development, Cell Expansion, and Virus Infiltration), Product (Instruments[Blood Gas Analyzers, Bioprocess Analyzers, and Osmometers], Cell Counters [Bioreactors, Incubators, and Others], and Consumables & Accessories[Culture Media, Reagents, and Others], and Others), Application (Biopharmaceuticals, Industry Chemicals, Environmental Management Aid, and Specialty Products), and End-user (Biotechnology & Biopharmaceutical Companies, Academic Research Institutes, Contract Manufacturing & Research Organizations, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Koninklijke Philips N.V.; F. Hoffmann-La Roche Ltd; FUJIFILM Holdings America Corporation; Catalent, Inc; Thermo Fisher Scientific Inc.; BD; Sartorius AG; Emerson Electric Co.; Univercells; Abbott; Danaher; Merck KGaA; GE Healthcare; Lonza; COLDER PRODUCTS COMPANY; Asahi Kasei Medical Co., Ltd; Boehringer Ingelheim International GmbH; Repligen Corporation; Corning Incorporated; Eppendorf SE; Solesis; LGC Limited; Nova Biomedical; Bio-Rad Laboratories, Inc. and Charles River Laboratories
|
Bioprocess Technology Market Segment Insights
What Key Factors Contribute to the Rapid Expansion of the Cell Culture Segment?
Growing Investment in Research and Technology
Based on type, the global bioprocess technology market is divided into cell culture, flow cytometry, cell line development, cell expansion, and virus infiltration. The cell culture type segment is expected to expand at a significant growth rate during the forecast period. The growth is attributed to the growing investment by prominent market players in research and technology.
The vast majority of protein therapeutics are produced with cell culture bioprocesses. Cell culture bioprocessing is an ideal system for studying the basics of cell biology and biochemistry. The growing research and technology development for developing drugs and treatments is fueling market growth.
The flow cytometry segment is also anticipated to grow at a considerable rate in the coming years owing to its powerful application in various disciplines such as virology, immunology, infectious disease monitoring, and cancer biology. Flow cytometry is widely beneficial in the effective study and understanding of the immune system and how it responds to cancer and infectious disease.
What are the Main Aspects for Boosting the Consumables & Accessories Segment?
Growing Rate of Adoption of Cell Culture Media
On the basis of product, the global market is segregated into instruments, cell counters, consumables & accessories, and others. The instruments segment is further subdivided into blood gas analyzers, bioprocess analyzers, and osmometers. The cell counters segment is further subclassified into bioreactors, incubators, and others. In addition, the consumables & accessories segment is sub-segmented into culture media, reagents, and others.
The consumables & accessories segment reported the largest share of the market in 2021 and is projected to register a considerable CAGR during the forecast period. The segment growth is owing to the growing rate of adoption of cell culture media across the globe for various research and development needs.
The instruments segment is also anticipated to witness rapid growth in the global bioprocess technology market owing to the rising technological advancements for advancing efficiency and cutting the risk of cross-contamination. In addition, the growing demand for biotechnology instrumentation is attributed to the increasing need for biotechnology tools in the pharmaceutical industry, biotech industry, and various other medical fields.
What are the Key Aspects that Boost the Biopharmaceutical Segment?
Increasing Demand for Biopharmaceuticals
On the basis of application, the global bioprocess technology market is segmented into biopharmaceuticals, industry chemicals, environmental management aid, and specialty products. The biopharmaceuticals segment is expected to grow rapidly during the projection period owing to a rise in production and demand for biopharmaceuticals across the globe. Biopharmaceuticals offer key benefits such as high effectiveness and lesser side effects, due to which their applications are rising in various disease treatments.
The industry chemicals segment is also anticipated to expand rapidly during the forecast period owing to the rising application of bioprocess technology in producing chemicals for various industrial production requirements. Producing chemicals through bioprocess technology enables reducing reliance on natural gas and oil, which in turn helps in reducing the environmental impact of the chemicals. Bioprocess technology is emerging as the most significant cost-effective form of producing industrial chemicals.
How is the Biotechnology & Biopharmaceutical Companies Segment generating more revenue share in the Global Bioprocess Technology Market?
Rising Demand for Advanced Vaccines and Drugs
On the basis of end-user, the global market is categorized into biotechnology & biopharmaceutical companies, academic research institutes, contract manufacturing & research organizations, and others. The biotechnology & biopharmaceutical companies segment held the largest share of the market in 2021, and it is expected to expand at a rapid pace during the projection period.
The growth of the segment is attributed to the rising demand for the development of advanced vaccines and drugs for chronic as well as rare diseases across the globe. Biotechnology holds high importance in the manufacturing of biopharmaceuticals.
The contract manufacturing & research organizations segment is expected to be the second-largest growing sub-segment in the end-user segment. The segment growth is owed to the increasing utilization of bioprocess technology advances to research and develop various drugs or vaccines on a contract basis by the contract manufacturing firms in the sector. The cost-effective solution offered by contract research or contract manufacturing organizations is fueling the growth of the biotechnology & pharmaceutical services outsourcing industry.
Why is North America Dominating the Global Bioprocess Technology Market?
Increasing Demand for Quality Biologics and Growing Investment in R&D by Key Players
In terms of region, the global bioprocess technology market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market size of North America is expected to dominate the global market during the forecast period. The increasing demand for superior quality biologics for treating various diseases as well as growing investment by the market key players in research and development is helping the market growth in the region. The advancement in biopharmaceuticals and manufacturing technology is expected to further fuel the market growth in North America in the coming years.
Asia Pacific region is also expected to witness rapid growth during the projection period in the global bioprocess technology market. The growing biopharmaceutical industry is one of the primary factors fueling the market growth in the region. Moreover, the increasing support by governments from emerging markets such as India and China is helping to rising investment in the bioprocess technology sector. Europe is also expected to grow steadily during the forecast period owing to a growing demand for biosimilars and the increasing prevalence of chronic diseases in the region.
Segments
The global bioprocess technology market has been segmented on the basis of
Type
- Cell Culture
- Flow Cytometry
- Cell Line Development
- Cell Expansion
- Virus Infiltration
Product
- Instruments
- Blood Gas Analyzers
- Bioprocess Analyzers
- Osmometers
- Cell Counters
- Bioreactors
- Incubators
- Others
- Consumables & Accessories
- Culture Media
- Reagents
- Others
- Others
Application
- Biopharmaceuticals
- Industry Chemicals
- Environmental Management Aid
- Specialty Products
End-user
- Biotechnology & Biopharmaceutical Companies
- Academic Research Institutes
- Contract Manufacturing & Research Organizations
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Koninklijke Philips N.V.,
- F. Hoffmann-La Roche Ltd
- FUJIFILM Holdings America Corporation
- Catalent, Inc
- Thermo Fisher Scientific Inc.
- BD
- Sartorius AG
- Emerson Electric Co.
- Univercells
- Abbott
- Danaher
- Merck KGaA
- GE Healthcare
- Lonza
- COLDER PRODUCTS COMPANY
- Asahi Kasei Medical Co., Ltd
- Boehringer Ingelheim International GmbH
- Repligen Corporation
- Eppendorf SE
- Solesis
- Corning Incorporated
- LGC Limited
- Nova Biomedical
- Bio-Rad Laboratories, Inc.
- Charles River Laboratories
Competitive Landscape
The competitive landscape of the global bioprocess technology market report provides key insights into the growth strategies and development initiatives implemented by the key players in the market.
Key players competing in the global bioprocess technology market are Koninklijke Philips N.V.; F. Hoffmann-La Roche Ltd; FUJIFILM Holdings America Corporation; Catalent, Inc; Thermo Fisher Scientific Inc.; BD; Sartorius AG; Emerson Electric Co.; Univercells; Abbott; Danaher; Merck KGaA; GE Healthcare; Lonza; COLDER PRODUCTS COMPANY; Asahi Kasei Medical Co., Ltd; Boehringer Ingelheim International GmbH; Repligen Corporation; Corning Incorporated; Eppendorf SE; Solesis; LGC Limited; Nova Biomedical; Bio-Rad Laboratories, Inc. and Charles River Laboratories.
Some of these major companies adopted various business development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share.
- On 19 October 2022, Univercells a well-known global life science company offering solutions for biologics manufacturing raised 44 million euros in the first close of the Series D financing round. The private investment came from prominent new investors from the United States and Belgium. The new investment is expected to support Quantoom Biosciences' RNA platform, the commercial expansion of Exothera's Jumet-based infrastructure, and Univercells’ global bioprocess technologies market growth.
- On 30 September 2022, the global life science group, Sartorius AG, through its French-listed subsidiary group, Sartorius Stedim Biotech successfully acquired Albumedix Ltd. Based in Nottingham, United Kingdom, Albumedix is a leading provider of recombinant albumin-based solutions.
Request For Customization
Enquiry Before Buying
Speak With Analyst
